1. Home
  2. CAAS vs FATE Comparison

CAAS vs FATE Comparison

Compare CAAS & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.35

Market Cap

123.7M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

131.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
FATE
Founded
N/A
2007
Country
China
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.7M
131.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CAAS
FATE
Price
$4.35
$1.07
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
26.9K
1.1M
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
5.68
N/A
EPS
1.11
N/A
Revenue
$725,260,000.00
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.87
N/A
Revenue Growth
16.72
N/A
52 Week Low
$3.50
$0.66
52 Week High
$5.37
$2.02

Technical Indicators

Market Signals
Indicator
CAAS
FATE
Relative Strength Index (RSI) 56.88 46.03
Support Level $4.06 $1.03
Resistance Level $4.43 $1.19
Average True Range (ATR) 0.15 0.08
MACD 0.03 0.01
Stochastic Oscillator 75.56 36.71

Price Performance

Historical Comparison
CAAS
FATE

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: